![](/img/cover-not-exists.png)
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
Richardson, P. G., Xie, W., Jagannath, S., Jakubowiak, A., Lonial, S., Raje, N. S., Alsina, M., Ghobrial, I. M., Schlossman, R. L., Munshi, N. C., Mazumder, A., Vesole, D. H., Kaufman, J. L., Colson,Volume:
123
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2013-07-517276
Date:
March, 2014
File:
PDF, 510 KB
english, 2014